VELCADE (bortezomib) is indicated for the treatment of adult patients with multiple myeloma.
You are now leaving VELCADE-hcp.com, the official site for VELCADE® (bortezomib).
This link will take you to the corporate Takeda Oncology website.
For medical inquiries or to report an adverse event or product complaint, contact us at:
40 Landsdowne Street
Cambridge, Massachusetts 02139